FDA Corrects Rule to Exempt Manufacturers of Certain INDs from Registration

Drug Industry Daily
A A
Manufacturers of investigational new drugs intended for research, teaching or chemical analysis do not have to register their establishments with the FDA, according to a revised final rule on the electronic registration of foreign and domestic facilities.

To View This Article:

Login

Subscribe To Drug Industry Daily